FORUM Pharmaceuticals

FORUM Pharmaceuticals develops, and commercializes small molecule therapeutics for the disorders of the central nervous system. Read more

226 Followers on Owler
226 Followers on Owler
226 Followers on Owler
226 Followers on Owler

FORUM Pharmaceuticals

FORUM Pharmaceuticals develops, and commercializes small molecule therapeutics for the disorders of the central nervous system. Read more

CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Founded:

2001

Status:

PrivateIndependent Company

Est. Annual Revenue
Est. Employees
Sector

Update Industry

FORUM PHARMACEUTICALS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Sarepta is one of FORUM Pharmaceuticals's top competitors. Sarepta is a Public company that was founded in Cambridge, Massachusetts in 1980. Sarepta is in the Pharmaceuticals field. Sarepta has 691 more employees vs. FORUM Pharmaceuticals.

Sage Therapeutics is perceived as one of FORUM Pharmaceuticals's biggest rivals. Sage Therapeutics was founded in 2010 in Cambridge, Massachusetts. Sage Therapeutics operates in the Pharmaceuticals industry. Sage Therapeutics generates $1.1B more revenue than FORUM Pharmaceuticals.

Seaside Therapeutics is a top competitor of FORUM Pharmaceuticals. Seaside Therapeutics's headquarters is in Cambridge, Massachusetts, and was founded in 2005. Seaside Therapeutics competes in the field. Seaside Therapeutics generates 342% of FORUM Pharmaceuticals's revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 175 a good estimate for FORUM Pharmaceuticals's Employee count?

FORUM Pharmaceuticals Acquisitions

No recent acquisitions found related to FORUM Pharmaceuticals

FORUM Pharmaceuticals Funding History

Since FORUM Pharmaceuticals was founded in 2001, it has participated in 4 rounds of funding. In total FORUM Pharmaceuticals has raised $126.7M. FORUM Pharmaceuticals' last funding round was on Oct 2008 for a total of $65.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series D
Oct 2008
$65M
-
Series C
Oct 2006
$24M
-
Series B
Nov 2004
$23M
-
Series A
Oct 2002
$14.7M

Since FORUM Pharmaceuticals was founded in 2001, it has participated in 4 rounds of funding. In total FORUM Pharmaceuticals has raised $126.7M. FORUM Pharmaceuticals' last funding round was on Oct 2008 for a total of $65.0M

FORUM Pharmaceuticals Investments

No recent investments found related to FORUM Pharmaceuticals

FORUM Pharmaceuticals News

March 26, 2016BioPortfolio

FORUM Pharma says encenicline fails to meet Phase III endpoints

Privatelyheld US drug developer FORUM Pharmaceuticals has released disappointing topline results from... See more »
March 25, 2016Genetic Engineering & Biotechnology News

FORUM Pharmaceuticals to Restructure After Phase III Failures

FORUM Pharmaceuticals said it will restructure its operations-including, apparently, layoffs-followin... See more »
March 24, 2016BioCentury

Forum downsizing after Phase III schizophrenia miss

Forum Pharmaceuticals Inc. (Waltham, Mass.) said encenicline (EVP-6124) missed the co-primary endpoin... See more »
March 23, 2016BioPortfolio

FORUM Pharmaceuticals Inc. Provides Update on Encenicline Phase 3 Clinical Trial Program in Cognitive Impairment in Schizophrenia

FORUM Pharmaceuticals Inc. today announced topline results from two Phase 3 clinical trials in patien... See more »
March 23, 2016Xconomy

Restructuring Looms for Forum as Neuro Drug Fails Key Clinical Test

Forum Pharmaceuticals has been pursuing a more than decade-long quest to develop a drug that might he... See more »

FORUM Pharmaceuticals Press Releases

September 15, 2015BUSINESS WIRE

FORUM Pharmaceuticals Inc. Updates Encenicline Phase 3 Clinical Trial Programs in Alzheimer's Disease and Cognitive Impairment in Schizophrenia

WALTHAM, Mass.--(BUSINESS WIRE)--During verbal discussions with the U.S. Food and Drug Administration... See more »
July 15, 2015BUSINESS WIRE

FORUM Pharmaceuticals Announces Publication of Encenicline Phase 2 Clinical Trial Results for Cognitive Impairment in Schizophrenia

WALTHAM, Mass.--(BUSINESS WIRE)--FORUM Pharmaceuticals Announces Publication of Encenicline Phase 2 C... See more »
June 22, 2015BUSINESS WIRE

FORUM Pharmaceuticals Inc. Receives FDA Fast Track Designation for Lead Compound Encenicline to Treat Cognitive Impairment in Schizophrenia

WALTHAM, Mass.--(BUSINESS WIRE)--FORUM Pharmaceuticals Inc. Receives FDA Fast Track Designation for L... See more »
June 11, 2015BUSINESS WIRE

FORUM Pharmaceuticals Inc. Completes Patient Enrollment in Pivotal Phase 3 Clinical Trial Program of Encenicline for Cognitive Impairment in Schizophrenia

WALTHAM, Mass.--(BUSINESS WIRE)--FORUM Pharmaceuticals Inc. Completes Patient Enrollment in Pivotal P... See more »
June 10, 2015BUSINESS WIRE

FORUM Pharmaceuticals Inc. Announces Presentations at Upcoming Industry and Investor Conferences

WALTHAM, Mass.--(BUSINESS WIRE)--FORUM Pharmaceuticals Inc. Announces Presentations at Upcoming Indus... See more »
May 18, 2015BUSINESS WIRE

FORUM Pharmaceuticals Inc. Relocates Corporate Headquarters to State-of-the-Art Facility in Waltham, Massachusetts

WALTHAM, Mass.--(BUSINESS WIRE)--FORUM Pharmaceuticals Inc. Relocates Corporate Headquarters to State... See more »
April 8, 2015BUSINESS WIRE

FORUM Pharmaceuticals Inc. to Participate in Needham & Company's 14th Annual Healthcare Conference

WATERTOWN, Mass.--(BUSINESS WIRE)--FORUM Pharmaceuticals Inc. to Participate in Needham & Company's 1... See more »

Social Media

FORUM Pharmaceuticals Headquarters

225 2nd Ave

Waltham, Massachusetts02451

617-225-4250

Driving Directions »

Trending Companies

FORUM Pharmaceuticals Summary

ABOUT

Overview

FORUM Pharmaceuticals develops, and commercializes small molecule therapeutics for the disorders of the central nervous system. FORUM Pharmaceuticals was founded in 2001. FORUM Pharmaceuticals' headquarters is located in Waltham, Massachusetts, USA 02...

Website

forumpharma.com

Frequently Asked Questions about FORUM Pharmaceuticals

  1. When was FORUM Pharmaceuticals founded?

    FORUM Pharmaceuticals was founded in 2001
  2. How much revenue does FORUM Pharmaceuticals generate?

    FORUM Pharmaceuticals generates $5M in revenue
  3. How much funding does FORUM Pharmaceuticals have?

    FORUM Pharmaceuticals has historically raised $126.7M in funding
  1. Where is FORUM Pharmaceuticals's headquarters?

    FORUM Pharmaceuticals's headquarters is in Waltham Massachusetts, USA
  2. How many employees does FORUM Pharmaceuticals have?

    FORUM Pharmaceuticals has 175 employees
  3. Who are FORUM Pharmaceuticals's competitors?

    FORUM Pharmaceuticals's top competitors are Sarepta, Sage Therapeutics, Seaside Therapeutics